SUNG PARK: Open Payments
NPI 1093457194 · HOLLISTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,234 in 42 payments from 11 companies in 2025. Trend: 2023 $4,567 · 2024 $253 · 2025 $1,234
Food & beverage: $1,234
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $307 |
| Otsuka America Pharmaceutical, Inc. | 8 | $275 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $142 |
| Janssen Pharmaceuticals, Inc | 3 | $122 |
| ACADIA Pharmaceuticals Inc | 2 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Noven Therapeutics, LLC | 2 | $47 |
| Janssen Scientific Affairs, LLC | 1 | $43 |
Products named: REXULTI, FANAPT, SPRAVATO, TRINTELLIX, HETLIOZ, NUPLAZID, CAPLYTA, Auvelity.
Industry payments across CA — which companies pay providers there.
